August 5, 2020

Volume X, Number 218

August 04, 2020

Subscribe to Latest Legal News and Analysis

August 03, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
2
Jan
Nothin’ from Nothin’ Leaves Nothin’: Axiom Worldwide Inc. v. Excite Medical Corp. et al. McDermott Will & Emery
30
Dec
Reissue Patents Must Be Drawn to the Same Invention as the Original Patent McDermott Will & Emery
30
Dec
The “Top Ten” Intellectual Property Stories of 2014 (Most “Definitely”) Schwegman, Lundberg & Woessner, P.A.
27
Dec
J.M. Smucker Company Gets Out of a Jam in Food Labelling Case - Caldera v. The J.M. Smucker Co. Sheppard, Mullin, Richter & Hampton LLP
26
Dec
Mandatory GMO Labeling: Perhaps Some Skepticism on the Hill Morgan, Lewis & Bockius LLP
26
Dec
Calorie Counts as Far as the Eye Can See: FDA Finalizes New Menu Labeling Rules Morgan, Lewis & Bockius LLP
24
Dec
Cyanotech Corp. v. The Board of Trustees of the University of Illinois: Final Written Decision IPR2013-00401 Faegre Drinker
23
Dec
U.S. Patent and Trademark Office Clarifies “Patent Eligible Subject” Matter in its Recent Guidance in Light of Alice Sheppard, Mullin, Richter & Hampton LLP
23
Dec
Health Care Law Update - December 22, 2014 Mintz
23
Dec
Ho Ho Ho GMO! The 2014 GMO Legislation Scorecard Mintz
20
Dec
Myriad's Breast Cancer Test Patents Not Patent Eligible Honigman Miller Schwartz and Cohn LLP
19
Dec
Supreme Court Asked To Decide Whether Colorado’s Marijuana Legalization Violates Constitution Jackson Lewis P.C.
19
Dec
CME Issues Revisions to Wash Trade Advisory Notice Katten
19
Dec
Legalized Loophole – Is Legalized Marijuana Truly “Lawful?” Barnes & Thornburg LLP
19
Dec
Buy High, Sell Low, and Restrict Competition: The Allegations Underlying the Government’s Case Against DaVita and the Implications of the Settlement Faegre Drinker
19
Dec
Generally Accepted Processing Practice (GAPP) Improves Michigan Food Processing Varnum LLP
19
Dec
CMS Issues Rewards and Incentive Guidance to Medicare Advantage (MA) Plans Mintz
19
Dec
U.S. Commerce Department Prioritizes Mozambique in 2015 Covington & Burling LLP
18
Dec
2014 Interim Guidance on Patent Subject Matter Eligibility Under Myriad and Nature-Based Products Barnes & Thornburg LLP
18
Dec
Revised Guidelines for Patentable Subject Matter Eligibility Vedder Price

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS